EMD-48430

Single-particle
3.5 Å
EMD-48430
3D View Gallery
Deposition: 22/12/2024
Map released: 14/01/2026
Last modified: 01/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-48430
Download
3D volume (map.gz) Experimental metadata (xml) Experimental Metadata (cif.gz)
Map-only Validation report (pdf.gz) Map-only Validation report (cif.gz) Map-only Validation report (xml.gz)
Map and PDB model 9mnm summary report (pdf.gz) Map and 9mnm FULL report (pdf.gz)
EMICSS annotations (xml)

SPA of purified HIV-1 CA protein in vitro assembled with IP6 (mature morphology). 500 uM LEN was added post assembly.

EMD-48430

Single-particle
3.5 Å
EMD-48430
3D View Gallery
Deposition: 22/12/2024
Map released: 14/01/2026
Last modified: 01/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: HIV-1, Human immunodeficiency virus type 1 BH10
Sample: HIV-1
Fitted models: 9mnm

Deposition Authors: Ricana CL, Dick RA
Lenacapavir prevents production of infectious HIV-1 by abrogating immature virus assembly.
Ricana CL, Brancato SG, Highland CM, Ekbataniamiri F, Ambrus K, Rey JS, Faerch M, Torbett BE, Perilla JR, Dick RA
(2026) bioRxiv
PUBMED: 41867786
DOI: doi:10.64898/2026.03.02.709178
ISSN: 2692-8205